The Molecular and Cell Biology (MCB) Support Core provides USC Norris Comprehensive Cancer Center (NCCC) researchers with glassware washing/sterilizing services and shared equipment purchase/ maintenance to support their molecular biology, cell biology, biochemistry, and molecular epidemiology experiments. The MCB Support Core: 1) washes/sterilizes glassware for individual research laboratories, and for the Bioreagent and Cell Culture Core for preparation of sterile culture media;2) prepares doubly deionized, distilled water in large quantities for preparation of reagents for molecular biology, cell biology, and biochemistry experiments;3) supervises/maintains all shared equipment;4) negotiates/administers service contracts for shared, heavily-used, expensive pieces of lab equipment (ECL-Western apparatus, phosphorimagers, ultracentrifuges. X-ray film developers, liquid scintillation counters, shared fluorescent microscopes);5) provides centralized supplies, including carbon dioxide, liquid nitrogen, and dry ice to NCCC labs;6) maintains freezers, refrigerators, balances, and spectrophotometers in individual labs;and 7) assesses needs/makes recommendations for purchase of new shared equipment/services. The Glassware Facilities of the MCB Support Core are located at four sites: Ezralow Tower (1,300 sq. ft., three autoclaves, three glassware washers), Harlyne Norris Research Tower (HNRT, 1,600 sq. ft., four glassware washers, three autoclaves). Cancer Research Laboratories (CRL, 1,000 sq. ft., one autoclave, one glassware washer), and Smith Research Tower at Childrens Hospital Los Angeles (CHLA, 1,000 sq. ft., one autoclave, one glassware washer). This shared resource serves 94 Cancer Center members and their research groups, 500 scientists/technical staff total. The CCSG supports 4.0 FTE glassware technicians;another two are supported by chargebacks. The MCB Support Core is supervised by Dr. Joseph R. Landolph, Associate Professor of Molecular Microbiology and Immunology. Mr. Kent Chang manages the Norris Headquarters and CRL. Dr. Ambrose Jong supervises CHLA facilities. In 2008, we occupied the 103,000 n.s.f. HNRT, housing 40 new Pis. As a result, this MCB Support Core has experienced a very large increased demand for services beginning in 2008 and continuing to the present time.

Public Health Relevance

The MCB Support Core supports research of NCCC members in molecular mechanisms of DNA repair, molecular mechanisms of DNA methylation, and molecular mechanisms of prostate tumor formation, among many research projects. Understanding these processes can lead to novel ways and new drugs to control these processes and thereby to reduce/prevent tumor formation in humans.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-39
Application #
8589343
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
39
Fiscal Year
2014
Total Cost
$272,255
Indirect Cost
$99,069
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Liu, Minmin; Zhang, Lian; Li, Hongtao et al. (2018) Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma. Hepatology 68:1412-1428
Miller, Kimberly A; Ramirez, Cynthia N; Wojcik, Katherine Y et al. (2018) Prevalence and correlates of health information-seeking among Hispanic and non-Hispanic childhood cancer survivors. Support Care Cancer 26:1305-1313
Belic, Jelena; Graf, Ricarda; Bauernhofer, Thomas et al. (2018) Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide. Int J Cancer 143:1236-1248
Tobin, Jessica; Allem, Jon-Patrick; Slaughter, Rhona et al. (2018) Posttraumatic growth among childhood cancer survivors: Associations with ethnicity, acculturation, and religious service attendance. J Psychosoc Oncol 36:175-188
Schaal, Justin B; Maretzky, Thorsten; Tran, Dat Q et al. (2018) Macrocyclic ?-defensins suppress tumor necrosis factor-? (TNF-?) shedding by inhibition of TNF-?-converting enzyme. J Biol Chem 293:2725-2734
Iriondo, Oihana; Liu, Yarong; Lee, Grace et al. (2018) TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nat Commun 9:1994
Robison, Nathan J; Yeo, Kee Kiat; Berliner, Adrian P et al. (2018) Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. J Neurooncol 138:199-207
Naseem, Madiha; Barzi, Afsaneh; Brezden-Masley, Christine et al. (2018) Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 66:15-22
Sebio, A; Stintzing, S; Heinemann, V et al. (2018) A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. Pharmacogenomics J 18:43-48
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472

Showing the most recent 10 out of 842 publications